US equities |
SNDK $1,150.89 ▲+0.00% MU $884.74 ▲+0.00% NVDA $204.64 ▲+0.00% INTC $65.76 ▲+0.00% SPCX $134.72 ▲+0.00% GOOGL $279.84 ▲+0.00% SKHY $149.21 ▲+0.00% TSLA $399.81 ▲+0.00%
FinancialContent

Articles published by Sofinnova Partners

News headline image
Sofinnova Partners Promotes Javier Nunez-Vicandi to Partner, Strengthening Its Digital Medicine Strategy
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Closes Oversubscribed €82 Million Sofinnova MD Start IV Fund to Create the Next Generation of Medtech Companies
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Appoints David Evans as Partner
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Closes €650M ($750M) Capital XI, Greatly Exceeding Initial Target to Back Early-Stage Healthcare Deals
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Collaborates With NVIDIA to Accelerate European Life Sciences Startups
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Exceeds Target With €165M Biotech Acceleration Fund, Europe’s Largest, With Strong Pharma Support
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Welcomes Agnès Pauquet as Head of Human Resources
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners appoints Karl Naegler as Partner
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Appoints Two New Partners Strengthening Team of Next Generation Investors
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Portfolio Company Amolyt Pharma to be Acquired by AstraZeneca
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Brings in Dr. Joshua Makower, Stanford Biodesign Co-Founder, as Venture Partner
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Welcomes Andrew M. Weiss as Venture Partner
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Launches Biovelocita, the First Pan-European Investment Strategy Dedicated to the Creation and Acceleration of Biotech Startups
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Unveils Sofinnova.AI: A Cutting-edge Artificial Intelligence Platform Set to Transform Its Life Sciences Investment Practice
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Enhances Leadership in Medtech Acceleration with Key Appointments
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Raises $200M Digital Medicine Fund
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Appoints Mary McCarthy as Partner for the Firm’s Industrial Biotech Strategy
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Launches Digital Medicine Strategy
From Sofinnova Partners
Via Business Wire
News headline image
Noema Pharma, Founded by Sofinnova Partners, Raises CHF 103 Million (USD 112 Million) in Series B Financing
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Welcomes Mano Iyer as Venture Partner
From Sofinnova Partners
Via Business Wire
News headline image
Sofinnova Partners Appoints Mats Eklund as Partner and Chief Operating Officer
From Sofinnova Partners
Via Business Wire
News headline image
AAVantgarde Announces the Appointment of Naveed Shams, M.D., Ph.D. as Chief Development and Medical Officer
From Sofinnova Partners
Via AccessWire
Topics Stocks
News headline image
Sofinnova Partners Announces New Investment In Nanophoria, Developer Of An Innovative Non-viral Drug Delivery Platform
From Sofinnova Partners
Via AccessWire
News headline image
GFBiochemicals raises €15m Series A to Advance its Mission to End Chemical Pollution
From Sofinnova Partners
Via AccessWire
News headline image
Sofinnova Partners Announces New Investment in Nephris, an Innovative Biotech Targeting Chronic Kidney Diseases
From Sofinnova Partners
Via AccessWire
News headline image
Gradient Denervation Technologies Announces Appointment of Martin Grasse as Chief Executive Officer
From Sofinnova Partners
Via AccessWire
News headline image
AAVantgarde Bio appoints Ram Palanki as Chairman of its Board of Directors
From Sofinnova Partners
Via AccessWire